An integrated knowledge database dedicated to ncRNAs, especially lncRNAs.

Detail infomation of NONHSAG027985.1

General info


NONCODE GENE IDNONHSAG027985.1
Chromosomechr2
Start Site64762117
End Site65056196
Strand-
Length18773
Assemblyhg38
ClassLinc;
Other Gene VersionsNONHSAG027985.2(old version)

Transcripts in Gene


NONCODE TRANSCRIPT ID

Expression Profile (Data Source:Human Body Map)

adiposeadrenalbrainbrain_Rbreastcolonforeskinheart
hela_RHLF_1HLF_2kidneyliverliver_RlunglymphNode
ovaryplacenta_RprostateskeltalMuscletestestestes_RthyroidwhiteBloodCell
NA

Exosome Expression Profile (Data Source: NCBI GEO)

NA

Conservation Info


  • Chordata
    • Vertebrates
      • Manmals
        • Primates
          • Human
          • Chimp : N/A
          • Gorilla : N/A
          • Orangutan : N/A
          • Rhesus : N/A
        • Rodents
          • Mouse : N/A
          • Rat : N/A
        • Laurasiatheria
          • Pig : N/A
          • Cow : N/A
        • Opossum : N/A
        • Platypus : N/A
      • Birds
        • Chicken : N/A
    • Actinopteryqii
      • Zebrafish : N/A

Note: T = There are transcripts in this region.


Disease related

Disease:

NONCODE IDGene SymbolDisease nameSource DatabaseSource PMID

Mutations:

NONCODE IDSNP IDGWAS traitSource PMID
NONHSAG027985.3rs847812Serum ratio of (4-hydroxyphenylacetate)/(quinate)21886157
NONHSAG027985.3rs847812Total cholesterol20686565
NONHSAG027985.3rs847812LDL cholesterol20686565
NONHSAG027985.3rs847811Gene expression of CFL2 in peripheral blood monocytes20502693
NONHSAG027985.3rs847811Serum ratio of (3-hydroxy-2-ethylpropionate)/(3-hydroxybutyrate (BHBA))21886157
NONHSAG027985.3rs2136451Serum ratio of (4-hydroxyphenylacetate)/(quinate)21886157
NONHSAG027985.3rs2136451Smoking cessation24665060
NONHSAG027985.3rs2136451Total cholesterol20686565
NONHSAG027985.3rs17608651Gene expression of USP38 in peripheral blood monocytes20502693
NONHSAG027985.3rs17608651Gene expression of SERTAD2 in peripheral blood monocytes20502693
NONHSAG027985.3rs17608651Serum ratio of (4-hydroxyphenylacetate)/(quinate)21886157
NONHSAG027985.3rs17608651Type 1 diabetes17554300
NONHSAG027985.3rs17608651Multiple complex diseases17554300
NONHSAG027985.3rs702874Total cholesterol20686565
NONHSAG027985.3rs847805Serum concentration of quinate21886157
NONHSAG027985.3rs6721629Serum ratio of (dodecanedioate)/(epiandrosterone sulfate)21886157
NONHSAG027985.3rs10469881Type 2 diabetes17463246
NONHSAG027985.3rs10469881Type 2 diabetes17463246
NONHSAG027985.3rs929699Chronic kidney disease20383146
NONHSAG027985.3rs929698Parkinson's disease17052657
NONHSAG027985.3rs929698Parkinson's disease (PD)17052657
NONHSAG027985.3rs929697Serum concentration of arginine21886157
NONHSAG027985.3rs7579416Smoking initiation24665060
NONHSAG027985.3rs6732883Serum ratio of (eicosapentaenoate (EPA; 20:5n3))/(nonadecanoate (19:0))21886157
NONHSAG027985.3rs17608884Autism with low IQ20663923
NONHSAG027985.3rs6546102Visceral adipose tissue (female)22589738
NONHSAG027985.3rs6704589Stabilized warfarin dose18535201
NONHSAG027985.3rs17029460Multiple complex diseases17554300
NONHSAG027985.3rs17029460Rheumatoid arthritis, combined control dataset, gender differentiated17554300
NONHSAG027985.3rs11683197Visceral fat22589738
NONHSAG027985.3rs11683197Visceral adipose tissue22589738
NONHSAG027985.3rs11678749Serum ratio of (bilirubin (E,Z or Z,E)*)/(saccharin)21886157
NONHSAG027985.3rs17661489Serum ratio of (1-methylxanthine)/(taurochenodeoxycholate)21886157
NONHSAG027985.3rs176615121-Methylnicotinamide:Asparagine21572414
NONHSAG027985.3rs17661512Gene expression of HPSE in peripheral blood monocytes20502693
NONHSAG027985.3rs176615121-Methylnicotinamide:Valine21572414
NONHSAG027985.3rs17661512Gene expression of EPS8L3 in peripheral blood monocytes20502693
NONHSAG027985.3rs176615121-Methylnicotinamide:Tyrosine21572414
NONHSAG027985.3rs176615121-Methylnicotinamide:Arginine21572414
NONHSAG027985.3rs17661512Serum ratio of (allantoin)/(glycodeoxycholate)21886157
NONHSAG027985.3rs1008631Serum ratio of (alanine)/(proline)21886157
NONHSAG027985.3rs1008631Serum concentration of hydroquinone sulfate21886157
NONHSAG027985.3rs6706514Serum ratio of (1-heptadecanoylglycerophosphocholine)/(1-oleoylglycerol (1-monoolein))21886157
NONHSAG027985.3rs4671615Serum ratio of (myristate (14:0))/(stearate (18:0))21886157
NONHSAG027985.3rs12373586Autism20663923
NONHSAG027985.3rs12373586Serum ratio of (hypoxanthine)/(indolelactate)21886157
NONHSAG027985.3rs12373586Autism with verbal ability20663923
NONHSAG027985.3rs12373586Celiac disease18311140
NONHSAG027985.3rs17661639Autism20663923
NONHSAG027985.3rs17661639Serum concentration of leucine21886157
NONHSAG027985.3rs6738590Serum phytosterol (brassicasterol)20529992
NONHSAG027985.3rs6738590Coronary artery disease (CAD)21606135
NONHSAG027985.3rs6738590Serum ratio of (3-methyl-2-oxovalerate)/(4-methyl-2-oxopentanoate)21886157
NONHSAG027985.3rs6738590Serum phytosterol20529992
NONHSAG027985.3rs6738590Serum phytosterol (brassicasterol normalized to cholesterol)20529992
NONHSAG027985.3rs741477Late onset Alzheimer's disease18823527
NONHSAG027985.3rs741477Late onset Alzheimer's disease21460841
NONHSAG027985.3rs7589570Serum ratio of (phenyllactate (PLA))/(pyroglutamine*)21886157
NONHSAG027985.3rs7589570Serum ratio of (gamma-glutamylleucine)/(propionylcarnitine)21886157
NONHSAG027985.3rs13026295Serum ratio of (1-methylurate)/(1-palmitoylglycerol (1-monopalmitin))21886157
NONHSAG027985.3rs13026295Autism20663923
NONHSAG027985.3rs7573247Serum ratio of (butyrylcarnitine)/(n-Butyl Oleate)21886157
NONHSAG027985.3rs7602986Rheumatoid arthritis20453842
NONHSAG027985.3rs4588172Serum ratio of (N-acetylthreonine)/(urea)21886157
NONHSAG027985.3rs4296412Gene expression of SERTAD2 in blood21829388
NONHSAG027985.3rs759664Serum ratio of (1-methylurate)/(4-acetamidobutanoate)21886157
NONHSAG027985.3rs9678117Gene expression of Contig22455_RC in liver18462017
NONHSAG027985.3rs9678117Serum concentration of phenol sulfate21886157
NONHSAG027985.3rs2048262Coronary artery disease (CAD)21378988
NONHSAG027985.3rs2048262Serum ratio of (7-methylguanine)/(allantoin)21886157
NONHSAG027985.3rs2048262Multiple complex diseases17554300
NONHSAG027985.3rs2048262Rheumatoid arthritis, gender differentiated17554300
NONHSAG027985.3rs6546107Serum ratio of (1-heptadecanoylglycerophosphocholine)/(N-(2-furoyl)glycine)21886157
NONHSAG027985.3rs6546108Height0
NONHSAG027985.3rs918197Serum ratio of (2-tetradecenoyl carnitine)/(biliverdin)21886157
NONHSAG027985.3rs918197Height0
NONHSAG027985.3rs918197Serum concentration of glutamine21886157
NONHSAG027985.3rs17029550Serum concentration of 1-heptadecanoylglycerophosphocholine21886157
NONHSAG027985.3rs918196Serum concentration of glutamine21886157
NONHSAG027985.3rs1995829Serum concentration of glutamine21886157
NONHSAG027985.3rs10490211Gene expression of PLA2G6 in peripheral blood monocytes20502693
NONHSAG027985.3rs10490211Serum ratio of (2-linoleoylglycerophosphocholine*)/(glycerol 2-phosphate)21886157
NONHSAG027985.3rs11126023Citrate:Glycine21572414
NONHSAG027985.3rs6761711Total cholesterol20686565
NONHSAG027985.3rs13022034Serum ratio of (7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca))/(lactate)21886157
NONHSAG027985.3rs13022034Gene expression of SLC1A4 in CHB-JPT lymphoblastoid cell lines17873874
NONHSAG027985.3rs13022034Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs13022383Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs13022383Gene expression of SLC1A4 in CHB-JPT lymphoblastoid cell lines17873874
NONHSAG027985.3rs13022383Serum ratio of (7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca))/(lactate)21886157
NONHSAG027985.3rs13022383Amyotrophic Lateral Sclerosis17362836
NONHSAG027985.3rs13022383Amyotrophic lateral sclerosis (ALS)17362836
NONHSAG027985.3rs13027905Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs13027905Gene expression of ETV3 in peripheral blood monocytes20502693
NONHSAG027985.3rs13027905Serum ratio of (3-(4-hydroxyphenyl)lactate)/(indolelactate)21886157
NONHSAG027985.3rs13027905Fasting insulin17463246
NONHSAG027985.3rs13027905Type 2 diabetes17463246
NONHSAG027985.3rs735473Gene expression of ACN9 in peripheral blood monocytes20502693
NONHSAG027985.3rs735473Gene expression of ZNF350 in peripheral blood monocytes20502693
NONHSAG027985.3rs4140738Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs4140738Ethanol concentration21572414
NONHSAG027985.3rs4140738Gene expression of ETV3 in peripheral blood monocytes20502693
NONHSAG027985.3rs4140738Serum ratio of (3-(4-hydroxyphenyl)lactate)/(indolelactate)21886157
NONHSAG027985.3rs4140738Fasting insulin17463246
NONHSAG027985.3rs2008831Gene expression of SLC1A4 in CEU-CHB-JPT lymphoblastoid cell lines17873874
NONHSAG027985.3rs2008831Amyotrophic lateral sclerosis (ALS)17362836
NONHSAG027985.3rs2008831Amyotrophic Lateral Sclerosis17362836
NONHSAG027985.3rs4671628Total cholesterol20686565
NONHSAG027985.3rs34610365Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs34610365Serum ratio of (3-(4-hydroxyphenyl)lactate)/(indolelactate)21886157
NONHSAG027985.3rs34610365Fasting insulin17463246
NONHSAG027985.3rs34610365Type 2 diabetes17463246
NONHSAG027985.3rs41537649Ethanol concentration21572414
NONHSAG027985.3rs41537649Serum ratio of (3-(4-hydroxyphenyl)lactate)/(indolelactate)21886157
NONHSAG027985.3rs41537649Fasting insulin17463246
NONHSAG027985.3rs41537649Type 2 diabetes17463246
NONHSAG027985.3rs11687281Serum ratio of (1,7-dimethylurate)/(mannitol)21886157
NONHSAG027985.3rs12473289Gene expression of SLC1A4 in CHB lymphoblastoid cell lines17873874
NONHSAG027985.3rs17029619Gene expression of SLC1A4 in CHB lymphoblastoid cell lines17873874
NONHSAG027985.3rs6754629Gene expression of SLC1A4 in blood21829388
NONHSAG027985.3rs6740379Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs17029623Gene expression of SLC1A4 in CHB lymphoblastoid cell lines17873874
NONHSAG027985.3rs12994797Gene expression of SLC1A4 in CEU-CHB-JPT-YRI lymphoblastoid cell lines17873874
NONHSAG027985.3rs4671629Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs4671629Gene expression of SLC1A4 in CHB lymphoblastoid cell lines17873874
NONHSAG027985.3rs4671629Serum ratio of (7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca))/(lactate)21886157
NONHSAG027985.3rs4671631Gene expression of SLC1A4 in CEU-CHB-JPT-YRI lymphoblastoid cell lines17873874
NONHSAG027985.3rs17029625Gene expression of SLC1A4 in CHB lymphoblastoid cell lines17873874
NONHSAG027985.3rs17029625Gene expression of NANS in peripheral blood monocytes20502693
NONHSAG027985.3rs4638779Gene expression of SLC1A4 in CEU-CHB-JPT-YRI lymphoblastoid cell lines17873874
NONHSAG027985.3rs918060Gene expression of SLC1A4 in CHB lymphoblastoid cell lines17873874
NONHSAG027985.3rs918060Serum ratio of (bilirubin (E,E)*)/(biliverdin)21886157
NONHSAG027985.3rs13008014Gene expression of SLC1A4 in CHB lymphoblastoid cell lines17873874
NONHSAG027985.3rs1035165Gene expression of SLC1A4 in CEU-CHB-JPT-YRI lymphoblastoid cell lines17873874
NONHSAG027985.3rs4671632Serum concentration of dimethylarginine (SDMA + ADMA)21886157
NONHSAG027985.3rs7571146C7-DC / PC aa C34:420037589
NONHSAG027985.3rs7571146Serum ratio of (1,6-anhydroglucose)/(4-vinylphenol sulfate)21886157
NONHSAG027985.3rs6740210Serum concentration of 7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)21886157
NONHSAG027985.3rs6546115Serum ratio of (quinate)/(sebacate (decanedioate))21886157
NONHSAG027985.3rs11126024Serum ratio of (1-methylxanthine)/(stearoylcarnitine)21886157
NONHSAG027985.3rs10490210Fasting insulin17463246
NONHSAG027985.3rs10490210Serum ratio of (glycodeoxycholate)/(trigonelline (N'-methylnicotinate))21886157
NONHSAG027985.3rs10490210HOMA-IR17463246
NONHSAG027985.3rs7576477Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs7576477Fasting insulin17463246
NONHSAG027985.3rs7576477Serum concentration of 7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)21886157
NONHSAG027985.3rs7590631Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs7590631Fasting insulin17463246
NONHSAG027985.3rs7590631Serum ratio of (dihomo-linolenate (20:3n3 or n6))/(indolelactate)21886157
NONHSAG027985.3rs7590631HOMA-IR17463246
NONHSAG027985.3rs13035939Gene expression of SLC1A4 in blood21829388
NONHSAG027985.3rs13035939Serum concentration of 2-aminobutyrate21886157
NONHSAG027985.3rs4671635Waist Circumference0
NONHSAG027985.3rs12999720Gene expression of SLC1A4 in peripheral blood monocytes20502693
NONHSAG027985.3rs12999720Serum ratio of (dihomo-linolenate (20:3n3 or n6))/(indolelactate)21886157
NONHSAG027985.3rs2017320Serum ratio of (3-methylxanthine)/(theobromine)21886157
NONHSAG027985.3rs2017320Waist Circumference0
NONHSAG027985.3rs759456Serum ratio of (3-methylxanthine)/(theobromine)21886157
NONHSAG027985.3rs17612862Serum concentration of ascorbate (Vitamin C)21886157
NONHSAG027985.3rs6706925Serum concentration of 2-aminobutyrate21886157
NONHSAG027985.3rs6706925Gene expression of SLC1A4 in blood21829388
NONHSAG027985.3rs4671636Gene expression of SLC1A4 in liver21637794
NONHSAG027985.3rs4671113Serum ratio of (2-linoleoylglycerophosphoethanolamine*)/(stachydrine)21886157
NONHSAG027985.3rs10211524Serum Ala/Val22286219
NONHSAG027985.3rs10211524Blood metabolite levels24816252
NONHSAG027985.3rs10211524Serum Leu/Val22286219
NONHSAG027985.3rs10211524Serum Phe/Val22286219
NONHSAG027985.3rs10211524Metabolite levels (atherosclerosis)22916037
NONHSAG027985.3rs10211524Serum metabolite network profiles22916037
NONHSAG027985.3rs6546118Gene expression of SPRED2 in peripheral blood monocytes20502693
NONHSAG027985.3rs6546118Gene expression of SLC1A4 [probe ILMN_12585] in osteoblasts treated with BMP221283786
NONHSAG027985.3rs9677813Gene expression of SLC1A4 [probe 209610_s_at] in prefrontal cortex20351726
NONHSAG027985.3rs6712664Serum ratio of (glycochenodeoxycholate)/(sebacate (decanedioate))21886157
NONHSAG027985.3rs10194107Serum Ala/Val22286219
NONHSAG027985.3rs12615528Gene expression of SLC1A4 (ENSG00000115902) in dendritic cells treated with Mycobacterium tuberculosis22233810
NONHSAG027985.3rs12615528Gene expression change of SLC1A4 (ENSG00000115902) in dendritic cells after treatment with Mycobacterium tuberculosis22233810
NONHSAG027985.3rs10170033Serum Ala/Val22286219
NONHSAG027985.3rs2007061Serum Ala/Val22286219
NONHSAG027985.3rs2160387Serum Ala/Val22286219
NONHSAG027985.3rs2160387Metabolite levels22286219
NONHSAG027985.3rs2160387Serum Leu/Val22286219
NONHSAG027985.3rs2160387Serum Phe/Val22286219
NONHSAG027985.3rs2160387Serum Val22286219
NONHSAG027985.3rs1541580Serum Ala/Val22286219
NONHSAG027985.3rs1541580Serum ratio of (2-aminobutyrate)/(alanine)21886157
NONHSAG027985.3rs1541580Serum concentration of 2-aminobutyrate21886157
NONHSAG027985.3rs1541580Alzheimer's disease20061627
NONHSAG027985.3rs3770707Serum Ala/Val22286219
NONHSAG027985.3rs3770706Serum Ala/Val22286219
NONHSAG027985.3rs3770705Change in depression severity with antidepressants (NRI or SRI)23091423
NONHSAG027985.3rs3770705Serum concentration of 2-aminobutyrate21886157
NONHSAG027985.3rs2422358Serum Ala/Val22286219
NONHSAG027985.3rs2422358Serum Leu/Val22286219
NONHSAG027985.3rs7583682Gene expression of SPRED2 in peripheral blood monocytes20502693
NONHSAG027985.3rs7583682Serum ratio of (7-methylxanthine)/(sebacate (decanedioate))21886157
NONHSAG027985.3rs7583682Triglycerides19060906
NONHSAG027985.3rs6546119Multiple complex diseases17554300
NONHSAG027985.3rs6546119Coronary artery disease (CAD), gender differentiated17554300
NONHSAG027985.3rs6546120Serum concentration of laurylcarnitine21886157
NONHSAG027985.3rs6546120Alzheimer's disease (APOE4 negative)19734902
NONHSAG027985.3rs6728107Serum concentration of pyroglutamylglycine21886157
NONHSAG027985.3rs759458Serum concentration of 1-methylxanthine21886157
NONHSAG027985.3rs759458Serum ratio of (hydroquinone sulfate)/(p-cresol sulfate)21886157
NONHSAG027985.3rs2075209Insulin disposition index19902172
NONHSAG027985.3rs10589223-Hydroxymandelate:Mannitol21572414
NONHSAG027985.3rs1058922Serum ratio of (2-linoleoylglycerophosphoethanolamine*)/(eicosapentaenoate (EPA; 20:5n3))21886157
NONHSAG027985.3rs2540970Gene expression of CEP68 in peripheral blood monocytes20502693
NONHSAG027985.3rs2540970Insulin disposition index19902172
NONHSAG027985.3rs2540970Gene expression of CEP68 [probe 2485688] in peripheral blood mononuclear cells19222302
NONHSAG027985.3rs2422435Smoking quantity24665060
NONHSAG027985.3rs2540964Major depressive disorder (broad definition) (males)20038947
NONHSAG027985.3rs2540959Gene expression of SLC1A4 [probe 212810_s_at] in prefrontal cortex20351726
NONHSAG027985.3rs7601712Serum concentration of laurylcarnitine21886157
NONHSAG027985.3rs2540953Serum concentration of 1,3,7-trimethylurate21886157
NONHSAG027985.3rs1009360Gene expression of CEP68 [probe 2485688] in peripheral blood mononuclear cells19222302
NONHSAG027985.3rs1009358Gene expression of CEP68 in peripheral blood monocytes20502693
NONHSAG027985.3rs1009358Gene expression of CEP68 (probeID ILMN_1808500) in cerebellum in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs1009358Gene expression of CEP68 (probeID ILMN_1808500) in temporal cortex in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs1009358HDL cholesterol20686565
NONHSAG027985.3rs1009358Serum concentration of pyridoxate21886157
NONHSAG027985.3rs2540951Gene expression of CEP68 (probeID ILMN_1808500) in cerebellum in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2540951Gene expression of CEP68 (probeID ILMN_1808500) in temporal cortex in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2540951HDL cholesterol20686565
NONHSAG027985.3rs7559813Serum ratio of (alanine)/(pseudouridine)21886157
NONHSAG027985.3rs7562809Serum metabolite (mass spec peak: 357.2 m/z)23281178
NONHSAG027985.3rs2540950Gene expression of CEP68 (ENSG00000011523) in dendritic cells treated with Mycobacterium tuberculosis22233810
NONHSAG027985.3rs2540950Gene expression of CEP68 in blood21829388
NONHSAG027985.3rs2540950Gene expression of CEP68 (probeID ILMN_1808500) in cerebellum in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2540950Serum ratio of (beta-hydroxyisovalerate)/(pyroglutamine*)21886157
NONHSAG027985.3rs2540950Gene expression of CEP68 (probeID ILMN_1808500) in temporal cortex in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2540950Gene expression of CEP68 [probe 2485688] in peripheral blood mononuclear cells19222302
NONHSAG027985.3rs2540950HDL cholesterol20686565
NONHSAG027985.3rs2540950Gene expression change of CEP68 (ENSG00000011523) in dendritic cells after treatment with Mycobacterium tuberculosis22233810
NONHSAG027985.3rs2540950Triglycerides20686565
NONHSAG027985.3rs2723066Gene expression of CEP68 (probeID ILMN_1808500) in cerebellum in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2723066Gene expression of CEP68 (probeID ILMN_1808500) in temporal cortex in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2723066HDL cholesterol20686565
NONHSAG027985.3rs2723066Triglycerides20686565
NONHSAG027985.3rs2723065Gene expression of CEP68 (probeID ILMN_1808500) in cerebellum in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2723065Gene expression of CEP68 (probeID ILMN_1808500) in temporal cortex in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2723065Gene expression of CEP68 (probeID ILMN_1808500) in cerebellum in Alzheimer's disease cases22685416
NONHSAG027985.3rs2723065HDL cholesterol20686565
NONHSAG027985.3rs2723062Gene expression of CEP68 (probeID ILMN_1808500) in cerebellum in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2723062Gene expression of CEP68 (probeID ILMN_1808500) in temporal cortex in Alzheimer's disease cases and controls22685416
NONHSAG027985.3rs2723062HDL cholesterol20686565
NONHSAG027985.3rs2302647Lung function, forced expiratory volume in 1 second (FEV1) decline by aspirin provocation21072201
NONHSAG027985.3rs2302647Gene expression of CEP68 in blood21829388
NONHSAG027985.3rs2302647Aspirin-intolerant asthma21072201

Potential Function


NA